Brian Taylor Slingsby, a director at $MLYS, sold 1,000,000 shares of the company on 11-20-2025 for an estimated $43,350,000. We received data on the trade from a recent SEC filing. This was a sale of approximately 11.2% of their shares of this class of stock. Following this trade, they now own 7,903,838 shares of this class of $MLYS stock.
$MLYS Insider Trading Activity
$MLYS insiders have traded $MLYS stock on the open market 41 times in the past 6 months. Of those trades, 2 have been purchases and 39 have been sales.
Here’s a breakdown of recent trading of $MLYS stock by insiders over the last 6 months:
- BRIAN TAYLOR SLINGSBY sold 1,000,000 shares for an estimated $43,350,000
- CAPITAL MANAGEMENT, L.P. RA purchased 1,176,470 shares for an estimated $29,999,985
- SRINIVAS AKKARAJU purchased 588,235 shares for an estimated $14,999,992
- JON CONGLETON (Chief Executive Officer) has made 0 purchases and 9 sales selling 230,984 shares for an estimated $9,963,256.
- ADAM SCOTT LEVY (CFO and Secretary) has made 0 purchases and 16 sales selling 214,718 shares for an estimated $7,048,630.
- ALEXANDER M GOLD has made 0 purchases and 5 sales selling 34,675 shares for an estimated $1,576,094.
- DAVID MALCOM RODMAN (Chief Medical Officer) has made 0 purchases and 6 sales selling 55,833 shares for an estimated $1,334,044.
- DAPHNE KARYDAS has made 0 purchases and 2 sales selling 15,000 shares for an estimated $689,797.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MLYS Hedge Fund Activity
We have seen 111 institutional investors add shares of $MLYS stock to their portfolio, and 96 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TCG CROSSOVER MANAGEMENT, LLC removed 2,470,265 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $33,422,685
- CITADEL ADVISORS LLC added 2,052,845 shares (+14273.7%) to their portfolio in Q3 2025, for an estimated $77,843,882
- POINT72 ASSET MANAGEMENT, L.P. added 1,799,628 shares (+inf%) to their portfolio in Q3 2025, for an estimated $68,241,893
- FMR LLC added 1,766,369 shares (+579.4%) to their portfolio in Q3 2025, for an estimated $66,980,712
- FARALLON CAPITAL MANAGEMENT LLC added 1,673,053 shares (+inf%) to their portfolio in Q3 2025, for an estimated $63,442,169
- HOLOCENE ADVISORS, LP added 1,205,377 shares (+inf%) to their portfolio in Q3 2025, for an estimated $45,707,895
- INTEGRAL HEALTH ASSET MANAGEMENT, LLC removed 1,200,000 shares (-44.4%) from their portfolio in Q3 2025, for an estimated $45,504,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MLYS Analyst Ratings
Wall Street analysts have issued reports on $MLYS in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 11/12/2025
- Wells Fargo issued a "Overweight" rating on 09/11/2025
- Goldman Sachs issued a "Buy" rating on 09/09/2025
- B of A Securities issued a "Buy" rating on 08/28/2025
To track analyst ratings and price targets for $MLYS, check out Quiver Quantitative's $MLYS forecast page.
$MLYS Price Targets
Multiple analysts have issued price targets for $MLYS recently. We have seen 5 analysts offer price targets for $MLYS in the last 6 months, with a median target of $52.0.
Here are some recent targets:
- Matthew Caufield from HC Wainwright & Co. set a target price of $56.0 on 11/12/2025
- Mohit Bansal from Wells Fargo set a target price of $55.0 on 11/11/2025
- Richard Law from Goldman Sachs set a target price of $52.0 on 09/09/2025
- Dennis Ding from Jefferies set a target price of $26.0 on 09/03/2025
- Greg Harrison from B of A Securities set a target price of $43.0 on 08/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
